Ilaria Milone
Overview
Explore the profile of Ilaria Milone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gagliardi D, Rizzuti M, Masrori P, Saccomanno D, Del Bo R, Sali L, et al.
J Neurol
. 2024 Sep;
271(12):7557-7571.
PMID: 39340541
Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disorder characterized by relentless and progressive loss of motor neurons. A molecular diagnosis, supported by the identification of specific biomarkers, might promote...
2.
Casiraghi V, Milone I, Brusati A, Peverelli S, Doretti A, Poletti B, et al.
J Neurol Sci
. 2024 Sep;
466:123210.
PMID: 39241471
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative condition affecting upper and/or lower motor neurons and characterized neuropathologically by TDP-43 proteinopathy. Given its role in ALS pathobiology, it is currently...
3.
Maranzano A, Verde F, Dubini A, Torre S, Colombo E, Doretti A, et al.
Eur J Neurol
. 2024 Jun;
31(9):e16374.
PMID: 38853763
Objective: Little is known about amyotrophic lateral sclerosis (ALS)-nonspecific cognitive deficits - most notably memory disturbance - and their biological underpinnings. We investigated the associations of the Alzheimer's disease (AD)...
4.
Verde F, Milone I, Colombo E, Maranzano A, Dubini A, Colombrita C, et al.
Neurol Sci
. 2023 Jun;
44(10):3697-3702.
PMID: 37369876
Introduction: Plasma levels of phosphorylated tau (P-tau181) have been recently reported to be increased in amyotrophic lateral sclerosis (ALS) and associated with lower motor neuron (LMN) impairment. Patients And Methods:...
5.
Verde F, Milone I, Dubini A, Colombrita C, Perego A, Solca F, et al.
Neurol Sci
. 2023 Jun;
44(9):3287-3290.
PMID: 37284933
Introduction: Alzheimer's disease (AD) is characterized by decreased cerebrospinal fluid (CSF) Aβ42 and Aβ42/Aβ40 ratio. Aβ peptides can now be measured also in plasma and are promising peripheral biomarkers for...
6.
Verde F, Milone I, Colombo E, Maranzano A, Solca F, Torre S, et al.
Front Aging Neurosci
. 2023 Apr;
15:1132808.
PMID: 37009451
Objective: To investigate the relationship between serum levels of the neuroaxonal degeneration biomarker neurofilament light chain (NFL) and phenotype in ALS. Materials And Methods: Serum NFL (sNFL) concentration was quantified...
7.
Aiello E, Verde F, Solca F, Milone I, Giacopuzzi Grigoli E, Dubini A, et al.
Neurol Sci
. 2023 Jan;
44(6):1979-1985.
PMID: 36705785
Background: The present study aimed to determine whether patients with mild cognitive impairment (MCI) and dementia due to Alzheimer's disease (AD), semantic verbal fluency (SVF), and the semantic-phonemic discrepancy (SPD)...
8.
Verde F, Ferrari I, Maranzano A, Ciusani E, Torre S, Milone I, et al.
Neurol Sci
. 2023 Jan;
44(5):1679-1685.
PMID: 36646859
Background: We analysed the relationship between cerebrospinal fluid (CSF)/serum albumin quotient (Q-Alb) and phenotype in a large cohort of patients with amyotrophic lateral sclerosis (ALS). Methods: Three hundred twenty-eight single-centre...
9.
Aiello E, Verde F, Milone I, Giacopuzzi Grigoli E, Dubini A, Carelli L, et al.
Front Psychol
. 2022 Dec;
13:1054321.
PMID: 36533021
Background: This study aimed at testing the ability of the frontal assessment battery (FAB) to differentiate between patients with mild cognitive impairment (MCI) and dementia due to Alzheimer's disease (AD),...
10.
Verde F, Milone I, Maranzano A, Colombo E, Torre S, Solca F, et al.
Ann Clin Transl Neurol
. 2022 Dec;
10(1):118-129.
PMID: 36525477
Objective: To compare serum levels of the astrocyte biomarker glial fibrillary acidic protein (GFAP) in patients with amyotrophic lateral sclerosis (ALS) and neurologically healthy controls and to analyze the relations...